australia's next csl?, page-14

Sorry ASH81 but your comments appear to be pure 'speculation' at the present time. There is currently no clinical evidence to date (that I am aware of, please correct me if I'm wrong) to support the two hypotheses that you have put forward regarding Vitrogro's diabetic ulcer healing rates,

i.e. "[that] the healing rate would be likely to improve further with more time" (i.e. longer than 6 weeks)

or...

"A higher healing rate would be expected using a normal population of ulcer sufferers".

Hopefully the latest clinical trials will shed some more light on Vitrogro's efficacy in these areas.

I would also point out that from the company's statements to date it appears that their intention at the present time is to focus on the 'chronic' diabetic ulcer market not patients who are already being successfully treated with existing treatments.